Plague vaccine development: Dynavax and DOD come to agreement
by Press Release from Outbreak News Today on (#5QEWB)
By NewsDesk @infectiousdiseasenews Biopharmaceutical company focused on developing and commercializing vaccines, Dynavax Technologies Corporation, and the U.S. Department of Defense (DOD) announced Dynavax has executed an agreement for approximately $22 million over two and a half years to develop a recombinant plague vaccine adjuvanted with CpG 1018(R). Under the agreement, Dynavax will conduct a Phase 2 clinical trial [...]
The post Plague vaccine development: Dynavax and DOD come to agreement appeared first on Outbreak News Today.